With Elsevier’s ClinicalPath (formerly Via Oncology), you can incorporate current, evidence-based, multi-disciplinary treatment approaches to support high-quality cancer care. As an integrated part of the decision workflow, you can access resources to surface the optimal patient-specific treatment recommendation, supported by latest evidence, to give confidence and guidance to the care you deliver.
Gain an up-close, real-world look at how cancer centers have uniquely leveraged oncology pathways in our whitepaper, Tackling Cancer Therapy Clinical Trial Management Challenges.
Narrow the band of variability in care decisions.
Evidence-based pathways seamlessly integrated into the workflow can support physicians in selecting the optimal treatment for each patient. ClinicalPath’s content is developed through a consistent, inclusive and transparent process, based on the latest evidence and prioritized by efficacy, toxicity and cost.
Succeed in value-based care with a multidisciplinary approach.
With ClinicalPath, you can coordinate consistent care across treatment modalities and support teams as patients move through the care continuum. With data demonstrating adherence to evidence-based treatment selection, pathways support payer metrics that can help institutions improve their position to negotiate and participate in value-based programs.
Prioritize clinical trials in the workflow.
With oncology pathways, you can take the guesswork out of accrual by putting available clinical trials at the point-of-care, increasing awareness for physicians. Incorporating trials into the workflow in a way that studies are prioritized as the first consideration before “standard of care” treatment options can result in an increase in patient screenings.
Join a collaborative network of oncology professionals at the forefront of caring for cancer patients, built on ClinicalPath’s 10+ years of experience working with leading oncology practices.
Cookies are used by this site. To decline or learn more, visit our cookie notice.